PAVmed Inc. Warrant
PAVMW
PAVMW was delisted on the 28th of January, 2022.
4 hedge funds and large institutions have $24K invested in PAVmed Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
2,300% more capital invested
Capital invested by funds: $1K → $24K (+$23K)
100% more funds holding
Funds holding: 2 → 4 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$16.4K |
| 2 |
VF
Virtu Financial
New York
|
+$15.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$22 |
PAVMW Hedge Fund Activity: Q4 2020 in Review
4 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q4 2020, worth a combined $24K — up 2,300% from $1K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PAVMW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $16.4K. The largest seller was UBS Group, cutting an estimated $22.
- 4 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q4 2020, up from 2 in Q3 2020.
- Funds reported $24K of PAVmed Inc. Warrant stock for Q4 2020, up 2,300% quarter-over-quarter.
- 2 funds opened new PAVmed Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +2 holders.
- The largest PAVmed Inc. Warrant buyer in Q4 2020 was Wolverine Asset Management, an estimated $16.4K added.
- The largest PAVmed Inc. Warrant seller in Q4 2020 was UBS Group, an estimated $22 sold.
Based on aggregated 13F filings for Q4 2020.